P30AG072959
Project Grant
Overview
Grant Description
Cleveland Alzheimer's Disease Research Center - Project Summary
The Cleveland Alzheimer's Disease Research Center (CADRC) is a collaborative effort of physicians and investigators from Case Western Reserve University (CWRU), Cleveland Clinic Foundation (CCF), MetroHealth System (MHS), University Hospitals (UH), and the Louis Stokes Cleveland VA Medical Center (LSCVAMC). Its aim is to foster excellence in research and facilitate discovery as an established National Institute on Aging (NIA) funded Alzheimer's Disease Research Center.
The CADRC represents a rich clinical and research community and serves an estimated 220,000 Ohioans who suffer from Alzheimer's Disease (AD) or AD-related dementias (ADRD). With 8 cores and a research education component, the CADRC is designed to enhance the research efforts of the Northeast Ohio AD/ADRD research community and provide unique value to the National Alzheimer's Disease Research Centers (ADRC) program, as well as other national and international research programs.
The CADRC focuses on participants who will help us understand the pathobiology of clinical and pathological heterogeneity observed in dementia, including atypical and amnestic AD, dementia with Lewy bodies, cognitively normal individuals with different levels of genetic risk for AD, and diversity of participant populations (clinical and outreach, recruitment, and engagement cores).
To support the CADRC goals, the focus will be on deep phenotyping of participants with longitudinal and systematic cognitive, behavioral, and motor characterization (clinical core), genetic and biofluid biomarker collection and analysis (biomarker core), imaging (neuroimaging core), and autopsy after death (neuropathology core). Results will be shared with the research community in a timely and regular manner to allow other investigators to benefit from the CADRC efforts (data management and statistics core).
In addition, the CADRC will train the next generation of investigators utilizing a rigorous and well-designed research education component, support the translation of new laboratory findings through the translational therapeutics core, and support high-risk/high-gain projects through the developmental program as part of the administrative core.
The ultimate goals of the CADRC are to advance the precision medicine approach to dementia diagnosis and treatment, support the development of early-stage investigators, assist all stages of investigators with tools for performing human-based research, and better engage underrepresented populations in AD/ADRD research.
The Cleveland Alzheimer's Disease Research Center (CADRC) is a collaborative effort of physicians and investigators from Case Western Reserve University (CWRU), Cleveland Clinic Foundation (CCF), MetroHealth System (MHS), University Hospitals (UH), and the Louis Stokes Cleveland VA Medical Center (LSCVAMC). Its aim is to foster excellence in research and facilitate discovery as an established National Institute on Aging (NIA) funded Alzheimer's Disease Research Center.
The CADRC represents a rich clinical and research community and serves an estimated 220,000 Ohioans who suffer from Alzheimer's Disease (AD) or AD-related dementias (ADRD). With 8 cores and a research education component, the CADRC is designed to enhance the research efforts of the Northeast Ohio AD/ADRD research community and provide unique value to the National Alzheimer's Disease Research Centers (ADRC) program, as well as other national and international research programs.
The CADRC focuses on participants who will help us understand the pathobiology of clinical and pathological heterogeneity observed in dementia, including atypical and amnestic AD, dementia with Lewy bodies, cognitively normal individuals with different levels of genetic risk for AD, and diversity of participant populations (clinical and outreach, recruitment, and engagement cores).
To support the CADRC goals, the focus will be on deep phenotyping of participants with longitudinal and systematic cognitive, behavioral, and motor characterization (clinical core), genetic and biofluid biomarker collection and analysis (biomarker core), imaging (neuroimaging core), and autopsy after death (neuropathology core). Results will be shared with the research community in a timely and regular manner to allow other investigators to benefit from the CADRC efforts (data management and statistics core).
In addition, the CADRC will train the next generation of investigators utilizing a rigorous and well-designed research education component, support the translation of new laboratory findings through the translational therapeutics core, and support high-risk/high-gain projects through the developmental program as part of the administrative core.
The ultimate goals of the CADRC are to advance the precision medicine approach to dementia diagnosis and treatment, support the development of early-stage investigators, assist all stages of investigators with tools for performing human-based research, and better engage underrepresented populations in AD/ADRD research.
Funding Goals
TO ENCOURAGE BIOMEDICAL, SOCIAL, AND BEHAVIORAL RESEARCH AND RESEARCH TRAINING DIRECTED TOWARD GREATER UNDERSTANDING OF THE AGING PROCESS AND THE DISEASES, SPECIAL PROBLEMS, AND NEEDS OF PEOPLE AS THEY AGE. THE NATIONAL INSTITUTE ON AGING HAS ESTABLISHED PROGRAMS TO PURSUE THESE GOALS. THE DIVISION OF AGING BIOLOGY EMPHASIZES UNDERSTANDING THE BASIC BIOLOGICAL PROCESSES OF AGING. THE DIVISION OF GERIATRICS AND CLINICAL GERONTOLOGY SUPPORTS RESEARCH TO IMPROVE THE ABILITIES OF HEALTH CARE PRACTITIONERS TO RESPOND TO THE DISEASES AND OTHER CLINICAL PROBLEMS OF OLDER PEOPLE. THE DIVISION OF BEHAVIORAL AND SOCIAL RESEARCH SUPPORTS RESEARCH THAT WILL LEAD TO GREATER UNDERSTANDING OF THE SOCIAL, CULTURAL, ECONOMIC AND PSYCHOLOGICAL FACTORS THAT AFFECT BOTH THE PROCESS OF GROWING OLD AND THE PLACE OF OLDER PEOPLE IN SOCIETY. THE DIVISION OF NEUROSCIENCE FOSTERS RESEARCH CONCERNED WITH THE AGE-RELATED CHANGES IN THE NERVOUS SYSTEM AS WELL AS THE RELATED SENSORY, PERCEPTUAL, AND COGNITIVE PROCESSES ASSOCIATED WITH AGING AND HAS A SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO EXPAND AND IMPROVE THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Cleveland,
Ohio
44195
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 397% from $3,090,243 to $15,367,621.
Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University was awarded
CADRC: Advancing Alzheimer's Research
Project Grant P30AG072959
worth $15,367,621
from National Institute on Aging in September 2021 with work to be completed primarily in Cleveland Ohio United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
9/1/21
Start Date
6/30/26
End Date
Funding Split
$15.4M
Federal Obligation
$0.0
Non-Federal Obligation
$15.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for P30AG072959
Transaction History
Modifications to P30AG072959
Additional Detail
Award ID FAIN
P30AG072959
SAI Number
P30AG072959-2116062026
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
M5QFLTCTSQN6
Awardee CAGE
0ZV10
Performance District
OH-11
Senators
Sherrod Brown
J.D. (James) Vance
J.D. (James) Vance
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) | Health research and training | Grants, subsidies, and contributions (41.0) | $6,150,412 | 100% |
Modified: 8/20/25